tiprankstipranks
Tyra Bioscience (TYRA)
NASDAQ:TYRA
US Market
TYRA
Tyra Bioscience
RESEARCH TOOLSreports
Want to see TYRA full AI Analyst Report?

Tyra Bioscience (TYRA) Stock News & Sentiment

126 Followers
Buy Rating on Tyra Biosciences Backed by Dabogratinib’s Potential to Redefine Intermediate-Risk Bladder Cancer Treatment Ahead of Key Phase II SURF302 Data
Premium
Ratings
Buy Rating on Tyra Biosciences Backed by Dabogratinib’s Potential to Redefine Intermediate-Risk Bladder Cancer Treatment Ahead of Key Phase II SURF302 Data
1d ago
TYRA
Dabogratinib’s Differentiated FGFR3 Profile and SURF302 Readout Position Tyra for Upside in Intermediate‑Risk NMIBC
Premium
Ratings
Dabogratinib’s Differentiated FGFR3 Profile and SURF302 Readout Position Tyra for Upside in Intermediate‑Risk NMIBC
15d ago
TYRA
Tyra Bioscience Expands Board, Appoints New Independent Director
Premium
Company Announcements
Tyra Bioscience Expands Board, Appoints New Independent Director
18d ago
8K
TYRA
Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch
Premium
Company Announcements
Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch
19d ago
TYRA
Tyra Bioscience Strengthens Financial Leadership with New Officer
Premium
Company Announcements
Tyra Bioscience Strengthens Financial Leadership with New Officer
1M ago
8K
TYRA
Tyra Bioscience Raises $126 Million in Block Share Sale
Premium
Company Announcements
Tyra Bioscience Raises $126 Million in Block Share Sale
2M ago
8K
TYRA
Tyra Biosciences: FGFR3-Focused Pipeline and Upcoming Clinical Catalysts Support Buy Rating and Favorable Risk‑Reward
Premium
Ratings
Tyra Biosciences: FGFR3-Focused Pipeline and Upcoming Clinical Catalysts Support Buy Rating and Favorable Risk‑Reward
2M ago
TYRA
More TYRA News >

TYRA News on the Web

Tyra Bioscience Expands Board, Appoints New Independent Director
TipRanks News
Neutral
Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch
TipRanks News
Bullish
Canaccord Genuity Sticks to Their Buy Rating for Tyra Bioscience (TYRA)
TipRanks News
Bullish
Tyra Biosciences initiated with a Buy at Guggenheim
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Tyra Bioscience (TYRA) and Amphastar Pharmaceuticals (AMPH)
TipRanks News
Bullish
Canaccord starts Tyra Biosciences at Buy into 2026 data readouts
TipRanks News
Neutral
Tyra Biosciences initiated with a Buy at Canaccord
TipRanks News
Bullish
Tyra Bioscience Strengthens Financial Leadership with New Officer
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
TYRA
Sector Average
Media Buzz
This Week5 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TYRA’s Media Buzz Sentiment?
5 articles about TYRA were published this week. In an average week, 2.75 articles are published.
    What is TYRA’s weekly average amount of articles?
    In an average week, 2.75 articles about TYRA are published.
      What is TYRA’s News Sentiment?
      100% of articles about TYRA were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week